Wolverine Asset Management LLC Mannkind Corp Put Options Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 04, 2024	SELL	$5.01 - $6.7 $10,020 - $13,400	-2,000 Reduced 3.4%	56,900 $357,000
Q2 2024 Aug 01, 2024	SELL	$4.05 - $5.43 $8,505 - $11,403	-2,100 Reduced 3.44%	58,900 $307,000
Q1 2024 May 13, 2024	SELL	$3.25 - $5.27 $320,775 - $520,148	-98,700 Reduced 61.8%	61,000 $276,000
Q3 2023 Nov 13, 2023	SELL	$3.91 - $5.45 $67,252 - $93,740	-17,200 Reduced 9.72%	159,700 $659,000
Q2 2023 Aug 07, 2023	BUY	$3.72 - $4.79 $153,264 - $197,348	41,200 Added 30.36%	176,900 $719,000
Q1 2023 May 08, 2023	BUY	$3.95 - $5.63 $12,640 - $18,016	3,200 Added 2.42%	135,700 $556,000
Q4 2022 Feb 01, 2023	BUY	$3.02 - $5.37 $400,150 - $711,525	132,500 New	132,500 $698,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.76B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.